comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 10:48:22 - browse：7

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Late stage cancers on the rise after pandemic delayed screenings

hotspot

WSS

White House announces new plan to address the growing threat of xylazine in overdose crisis

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Pharma showers House GOP doctor with campaign cash

Create a giant ice tray with this foil pan hack to keep food cold this summer

'Null' research findings aren't empty of meaning. Let's publish them

focus

comprehensive

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The cancer stories no one wants to hear

Dobbs anniversary: the lost opportunity of abortion as health care

Presidential fundraising highlights so far: Trump brings in more than DeSantis

Trump demands the U.S. pay no more for drugs than other countries … again

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Wildfire smoke exposes gaps in outdoor worker protections

Alnylam reports growth in sales of rare disease treatments

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech startup Celsius cuts 75% of staff ahead of first trial start

explore

Chris Christie meets with Zelenskyy during Ukraine trip

'Null' research findings aren't empty of meaning. Let's publish them

Recent heat wave in the Mediterranean caused by climate change: Study

Biotech startup Celsius cuts 75% of staff ahead of first trial start

When waiting feels immoral: Empathy in the emergency department

Pharma showers House GOP doctor with campaign cash

leisure time

hotspot

hotspot

focus